NEW

Switch to Dark

Pricing

Learn

ISRG - Intuitive Surgical Inc

438

$480.67

-$2.09 (-0.433%)

3/18/26, 6:54 PM

3.70/5

General

Scores

Financials & KPIs

Dividends

Analyst

Insider

Income Statement Summary

Metrics

5

KPIs

View as %

Intuitive Surgical Inc

Stock Unlock

Sign Up

Legend	CAGR	Total Change	Average	Median	Low	High	Latest
Total Revenue	37.61%	27.19%	$2.52B	$2.47B	$2.25B 2025-03-31	$2.87B 2025-12-31	$2.87B 2025-12-31

Operating Expenses	25.87%	18.92%	$922.10M	$888.35M	$872.30M 2025-06-30	$1.04B 2025-12-31	$1.04B 2025-12-31

Net Interest Income Expense	1.32%	1%	$91.48M	$90.85M	$88.70M 2025-06-30	$95.50M 2025-09-30	$91.30M 2025-12-31

Income Tax Expense	--	--	$108.70M	$151.05M	-$35.20M 2025-03-31	$167.90M 2025-06-30	$156.10M 2025-12-31

Cost of Goods Sold (COGS)	28.63%	20.89%	$855.60M	$832.40M	$795.70M 2025-03-31	$961.90M 2025-12-31	$961.90M 2025-12-31

Income Statement

Balance Sheet

Cash Flow

Metrics

KPIs

% Change

Colors

.

#'s in thousands USD	All Time	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31 Get more features by creating a free Stock Unlock account: 2 portfolios, 5 positions per portfolio 2 watchlists, up to 10 tickers per watchlist More screener searches See full feature list	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30
Total Revenue		2,866,200	2,505,100	2,440,000	2,253,400	42,069,000	2281904	6903916	5397535	4331300	4296104	5638023	32362	4175459	6354999	5692503	9178438	9071458	9897314
Cost of Goods Sold (COGS)		961,900	842,700	822,100	795,700	42,069,000	2263463	4914804	1326359	7865738	9786074	6797914	8462847	242888	3337062	6681460	7101185	9426819	7784112
Gross Profit		1,904,300	1,662,400	1,617,900	1,457,700	42,069,000	1954643	3224231	4571468	1472022	5265670	1490141	891864	9301832	6318421	1324052	4058895	3492520	7505246
Operating Expenses		1,039,400	902,700	872,300	874,000	42,069,000	1974268	5039956	621299	502821	1110343	7891775	6382304	2790911	7126762	9488656	3635200	1414958	2641906
Research & Development		352,900	329,400	311,100	310,600	42,069,000	2566928	6698289	8919089	6800431	180933	3356426	8496686	6750614	9268138	3761385	4325793	2666401	4464206
Selling, General & Administrative Expenses		687,100	573,300	561,100	562,900	42,069,000	3129409	3445899	1248969	4313729	4345021	1928061	4831626	2971119	375072	3874374	555924	2257499	3015150
Operating Income or Loss		864,900	759,700	745,600	583,700	42,069,000	4496514	918465	5757416	1815423	7223838	7079391	497586	3504078	6817193	6242221	5876412	7498126	2144404
Interest Expense		--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--	--
Net Interest Income Expense		91,300	95,500	88,700	90,400	42,069,000	4478410	9911245	2781451	4096334	4775320	1781796	2626732	9298194	7346027	5614823	1054714	6360647	2035646
Non-Recurring Items		-600	--	-2,200	-5,600	-6,100	7277992	5139100	7183705	8571930	1313622	5863614	9545352	2388932	772751	1195698	1227365	3263328	4746828
Income Before Tax		955,600	855,200	832,100	668,500	42,069,000	8883993	457598	7746147	9936800	6192163	2349312	3003924	2046855	7412443	401115	8790867	267814	535756
Income Tax Expense		156,100	146,000	167,900	-35,200	42,069,000	313493	1913193	9216757	2965391	8415136	8902829	5918593	5662800	2068876	8786799	7460496	4979841	3001897
Earnings		794,800	704,400	658,400	698,400	42,069,000	357752	7768159	7396780	5899170	6753760	9317119	1297211	1954816	1068450	8948088	4537242	4050269	9590195
Adjusted Net Income		794,200	--	656,200	692,800	679,600	8187528	6357765	473755	9491267	1109756	4618226	8990352	6461145	6363607	4962560	7015520	5906741	9969867
Net Income After Taxes		799,500	709,200	664,200	703,700	42,069,000	6788193	4263497	277264	4663032	7155579	4602108	242944	8497805	1296009	4622243	2828788	7000439	3548669
Diluted Shares Outstanding		360,300	361,800	364,100	364,600	42,069	2361902	2149056	3827856	1012586	2558154	3446881	5328670	4070909	8506947	3416298	4413232	3654483	3734922
Diluted EPS		2.21	1.95	1.81	1.92	42,069	3659646	4686382	3559978	7655076	635040	7727693	8358603	8199269	1868932	5769723	9208871	6271979	6819203
Adjusted EPS		2.2	--	1.8	1.9	1.87	1497771	5947534	2200722	822664	3815243	8638994	775159	358316	9673084	9358074	8727524	810745	938843
EBITDA		1,058,400	929,300	910,000	733,300	42,069,000	6734929	9829526	8127234	6635220	3189249	4724247	2685591	1129513	9886693	7778318	8408577	2259916	5701518